Previous 10 | Next 10 |
Viatris Inc. (VTRS) 41st Annual J.P. Morgan Healthcare Conference January 11, 2023 06:00 PM ET Company Participants Michael Goettler - CEO Rajiv Malik - President Jeffrey Nau - Head, Eye Care Conference Call Participants Chris Schott - JPMorgan Presen...
Summary Dividend investing can work over time and anyone can create an ever growing passive income stream. My year over year progress is moving at a nice clip. Grand total for 2022 dividends: $14,496.97. The beginning of every month is exciting for...
Summary SPDV is an ETF holding five S&P 500 stocks in each sector in equal weight. Constituents are selected based on dividend yield and free cash flow. Valuation and dividend growth metrics look good. Quality and past performance are just average. This dividend ...
Nyxol ® Eye Drops Potentially Offer Differentiated Mechanism of Action to Treat Age-Related Blurry Near Vision Launch of Presbyopia Phase 3 Program Supported by Positive Clinical Results that Demonstrated Durable Efficacy and Favorable Safety Profile FARMING...
Summary In today's article, we provide a fourth-quarter update on our Inverse Jim Cramer strategy analyzing the performance, or lack thereof, behind his top-mentioned stock recommendations. This was yet another quarter in which we showed that inverting Jim Cramer's highest conviction pi...
The past year was a rough one for the stock market, with the S&P 500 falling 19.4% in 2022. But the result of this downturn is that investors now have some attractive stock-buying opportunities. For instance, share prices of Viatris (NASDAQ: VTRS) , General Motors (NYSE:...
Viatris ( NASDAQ: VTRS ) on Tuesday formally closed its acquisition of Oyster Point Pharma and Famy Life Sciences , and as a result established the Viatris ( VTRS ) Eye Care Division. Viatris ( VTRS ) paid ~$415M in cash upfront for Oyster Point plus a plus a cont...
Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences, Establishing New Viatris Eye Care Division PR Newswire Division Combines Oyster Point Pharma's Eye Care Expertise with Famy Life Science's Phase III-ready Pipeline and Lays Foundation for Viatris to Bec...
Summary DON is a mid-cap dividend ETF with a monthly distribution. Financials represent 24% of asset value. Valuation and quality metrics look a bit better than the S&P Midcap 400. Historical performance is close to the mid-cap benchmark. This dividend ETF article ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips With the healthcare sector poised to grow significantly in the coming years, healthcare stocks to buy present a fantastic opportunity for investors. Healthcare is something that everyone will need at some point in their lives, ...
News, Short Squeeze, Breakout and More Instantly...
NORTHAMPTON, MA / ACCESSWIRE / July 23, 2024 / No country can make every medicine people need, and no medicine is made in every country. If a country or region relies on supply only from within their region and they experience a crisis, there is a risk people won't get the medicines they need, w...
NORTHAMPTON, MA / ACCESSWIRE / July 18, 2024 / Viatris is a global healthcare company focused on bringing high-quality medicines to patients through a hybrid approach that bridges the traditional divide between generics and brands, combining the best of both, to more holistically address healthc...
2024-07-15 10:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...